Ryman’s turnaround is well under way: Forsyth Barr

Ryman’s turnaround is well under way: Forsyth Barr
Forsyth Barr's Aaron Ibbotson rates Ryman shares as "outperform". (Image: Forsyth Barr)
Jenny Ruth
Forsyth Barr analyst Aaron Ibbotson has taken a deep dive into Ryman Healthcare‘s debt position and its turnaround strategy and concluded it is “changing its stripes more than the market is giving it credit for”.The market has certainly exhibited extreme disillusion with the stock in recent weeks.Ryman shares fell as low as $4.82 after it completed its $902 million capital raising, compared with the rights issue price of $5 per new share and $6.40 before the mid-February announcement.The shares closed at $5.22 on Tuesday.A goo...

More Markets

NZ sharemarket dips ahead of Mainfreight, Infratil results
Markets Market Close

NZ sharemarket dips ahead of Mainfreight, Infratil results

The S&P/NZX 50 Index closed down 0.09% or 12.932 points to 13,604.55.

Tom Raynel 11 Nov 2025
Nearly 56% of votes cast so far support Comvita deal
Primary Sector

Nearly 56% of votes cast so far support Comvita deal

Its biggest shareholder has backed the Florenz deal.

Riley Kennedy 11 Nov 2025
Home-loan rivalry set to spice up as ANZ loses market share
Finance

Home-loan rivalry set to spice up as ANZ loses market share

ANZ NZ's underlying full-year profit eases higher as it eyes home-loan offering. 

Andy Macdonald 11 Nov 2025
NZX flat after Vital announcement
Markets

NZX flat after Vital announcement

The NZX was flat, but property stocks declined more than 1%.

Graham Skellern 10 Nov 2025